• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可改变的生活方式风险因素对前列腺癌预防的影响:文献综述

Impact of modifiable lifestyle risk factors for prostate cancer prevention: a review of the literature.

作者信息

Ziglioli Francesco, Patera Annalisa, Isgrò Gianmarco, Campobasso Davide, Guarino Giulio, Maestroni Umberto

机构信息

Department of Urology, University Hospital of Parma, Parma, Italy.

Department of Urology, James Cook University Hospital, Middlesbrough, United Kingdom.

出版信息

Front Oncol. 2023 Sep 8;13:1203791. doi: 10.3389/fonc.2023.1203791. eCollection 2023.

DOI:10.3389/fonc.2023.1203791
PMID:37746271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515617/
Abstract

INTRODUCTION

Although prostate cancer (PCa) is one of the most common cancers among men, the impact of modifiable risk and protective factors is still being debated. This review aims to qualitatively summarize the most recent studies related to potential healthy lifestyle factors affecting the development of PCa.

METHODS FOR DATA ACQUISITION

The literature focusing on modifiable risk factors for prostate cancer was reviewed. Medline and Embase via the Ovid database were searched, and all relevant and inherent articles were analyzed. Non-eligible publications, such as review articles, editorials, comments, guidelines, or case reports, were excluded.

SYNTHESIS OF THE EVIDENCE OBTAINED FROM DATA ANALYSIS

This review confirms that there is strong evidence that being overweight or obese increases the risk of advanced prostate cancer (assessed by body mass index (BMI), waist circumference, and waist-hip ratio), particularly considering central adiposity and ethnicity as contributing factors. The possible contribution of smoking still seems not entirely clear, while alcohol seems to affect PCa prevention in patients taking 5α-reductase inhibitors (5-ARIs). Dietary fibers may have anti-inflammatory properties and improve insulin sensitivity by reducing IGF bioactivity. In particular, dietary fiber intake like insoluble and legume fibers may be inversely associated with prostate cancer risk. Also, hyperglycemia and hyperinsulinemia, with untreated diabetic fasting blood glucose levels, could be modifiable prostate cancer risk factors. In two studies, aspirin was associated with a lower risk of lethal PCa and overall mortality. Concerning the role of vitamins, despite conflicting and divergent results, serum retinol concentration seems to be associated with an increased risk of prostate cancer and high-grade prostate cancer. Some studies resulted in disagreement about the role of selenium and vitamin E. We found inconsistent and controversial findings about the association between vitamin D and prostate cancer risk.

CONCLUSION

Far from being conclusive evidence, our findings confirm some strong evidence already found in the previous literature and highlight the need to clarify the role of some risk factors whose role is not yet completely known. This effort would facilitate the cultural and social change that may allow the shift from the treatment of prostate cancer when diagnosed to the real efforts needed for systematic prevention.

摘要

引言

尽管前列腺癌是男性中最常见的癌症之一,但可改变的风险因素和保护因素的影响仍存在争议。本综述旨在定性总结与影响前列腺癌发生的潜在健康生活方式因素相关的最新研究。

数据获取方法

对聚焦于前列腺癌可改变风险因素的文献进行综述。通过Ovid数据库检索Medline和Embase,并分析所有相关及内在的文章。排除不符合条件的出版物,如综述文章、社论、评论、指南或病例报告。

数据分析所得证据的综合

本综述证实,有强有力的证据表明超重或肥胖会增加晚期前列腺癌的风险(通过体重指数(BMI)、腰围和腰臀比评估),尤其考虑到中心性肥胖和种族是促成因素。吸烟的可能影响似乎仍不完全明确,而酒精似乎对服用5α-还原酶抑制剂(5-ARIs)的患者的前列腺癌预防有影响。膳食纤维可能具有抗炎特性,并通过降低胰岛素样生长因子(IGF)生物活性来改善胰岛素敏感性。特别是,不溶性纤维和豆类纤维等膳食纤维摄入量可能与前列腺癌风险呈负相关。此外,高血糖和高胰岛素血症,以及未经治疗的糖尿病空腹血糖水平,可能是可改变的前列腺癌风险因素。在两项研究中,阿司匹林与致命性前列腺癌风险降低及总体死亡率降低相关。关于维生素的作用,尽管结果相互矛盾且不一致,但血清视黄醇浓度似乎与前列腺癌和高级别前列腺癌风险增加相关。一些研究对硒和维生素E的作用存在分歧。我们发现关于维生素D与前列腺癌风险之间的关联存在不一致且有争议的结果。

结论

我们的研究结果远非确凿证据,而是证实了先前文献中已发现的一些强有力的证据,并强调需要阐明一些作用尚未完全明确的风险因素的作用。这项工作将促进文化和社会变革,从而有可能实现从前列腺癌确诊时的治疗向系统预防所需的实际努力的转变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdc/10515617/e41c20e67853/fonc-13-1203791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdc/10515617/e41c20e67853/fonc-13-1203791-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fdc/10515617/e41c20e67853/fonc-13-1203791-g001.jpg

相似文献

1
Impact of modifiable lifestyle risk factors for prostate cancer prevention: a review of the literature.可改变的生活方式风险因素对前列腺癌预防的影响:文献综述
Front Oncol. 2023 Sep 8;13:1203791. doi: 10.3389/fonc.2023.1203791. eCollection 2023.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.代谢性疾病、药物和饮食因素对前列腺癌风险、复发和生存的影响:欧洲泌尿外科学会肿瘤泌尿学分会的系统评价。
Eur Urol Focus. 2019 Nov;5(6):1029-1057. doi: 10.1016/j.euf.2018.04.001. Epub 2018 Apr 13.
4
Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU).最新证据表明,吸烟、运动和性行为是可改变的生活方式风险因素,会影响前列腺癌的发病、复发和进展:欧洲泌尿外科学会肿瘤泌尿外科学分会(ESOU)对文献的系统评价。
Eur Urol Focus. 2019 Sep;5(5):756-787. doi: 10.1016/j.euf.2018.02.007. Epub 2018 Mar 23.
5
6
7
8
Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.机器人辅助微创手术在妇科和泌尿外科肿瘤学中的应用:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.
9
10
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.

引用本文的文献

1
The Association of and Expression Profile in Patients with Prostate Cancer History.有前列腺癌病史患者中[具体内容缺失]与[具体内容缺失]表达谱的关联
Adv Biomed Res. 2025 Jul 21;14:65. doi: 10.4103/abr.abr_419_24. eCollection 2025.
2
Role of Tumor Microenvironment in Prostate Cancer Immunometabolism.肿瘤微环境在前列腺癌免疫代谢中的作用
Biomolecules. 2025 Jun 6;15(6):826. doi: 10.3390/biom15060826.
3
Diagnostic Stratification of Prostate Cancer Through Blood-Based Biochemical and Inflammatory Markers.通过基于血液的生化和炎症标志物对前列腺癌进行诊断分层

本文引用的文献

1
MR-based simplified extraprostatic extension evaluation: comparison of performances of different predictive models.基于磁共振成像的简化前列腺外扩展评估:不同预测模型的性能比较
Eur Radiol. 2023 Apr;33(4):2975-2984. doi: 10.1007/s00330-022-09240-1. Epub 2022 Dec 13.
2
PSA-IgM and iXip in the diagnosis and management of prostate cancer: clinical relevance and future potential. A review.PSA-IgM 和 iXip 在前列腺癌的诊断和治疗中的作用:临床相关性和未来潜力。综述。
Acta Biomed. 2022 Jan 19;92(6):e2021344. doi: 10.23750/abm.v92i6.12058.
3
Drug use disorder and risk of incident and fatal prostate cancer among Swedish men: a nationwide epidemiological study.
Diagnostics (Basel). 2025 May 30;15(11):1385. doi: 10.3390/diagnostics15111385.
4
Identification of Factors Affecting Prostate Cancer Using Machine Learning Methods: A Systematic Review.使用机器学习方法识别影响前列腺癌的因素:一项系统综述。
Asian Pac J Cancer Prev. 2025 May 1;26(5):1519-1528. doi: 10.31557/APJCP.2025.26.5.1519.
5
Fatigue Level Associated with Quality of Life for Prostate Cancer Patients: Results from the All of Us Research Program.前列腺癌患者的疲劳程度与生活质量的关系:来自“我们所有人”研究项目的结果。
Cancers (Basel). 2025 Apr 30;17(9):1531. doi: 10.3390/cancers17091531.
6
Role of multi‑omics in advancing the understanding and treatment of prostate cancer (Review).多组学在促进前列腺癌理解与治疗中的作用(综述)
Mol Med Rep. 2025 May;31(5). doi: 10.3892/mmr.2025.13495. Epub 2025 Mar 21.
7
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms.降低前列腺癌风险:频繁射精相关机制的作用
Cancers (Basel). 2025 Feb 28;17(5):843. doi: 10.3390/cancers17050843.
8
Prediagnostic Plasma Nutrimetabolomics and Prostate Cancer Risk: A Nested Case-Control Analysis Within the EPIC Study.诊断前血浆营养代谢组学与前列腺癌风险:欧洲癌症与营养前瞻性研究(EPIC)中的一项巢式病例对照分析
Cancers (Basel). 2024 Dec 8;16(23):4116. doi: 10.3390/cancers16234116.
9
Rapid Lifestyle Recommendations to Improve Urologic, Heart and Overall Health.快速生活方式建议,改善泌尿科、心脏和整体健康。
Curr Urol Rep. 2024 Oct 8;26(1):10. doi: 10.1007/s11934-024-01246-0.
10
Circum-Mediterranean influence in the Y-chromosome lineages associated with prostate cancer in Mexican men: A Converso heritage founder effect?环地中海地区对墨西哥男性前列腺癌相关 Y 染色体谱系的影响:康索罗特人遗传创始人效应?
PLoS One. 2024 Aug 16;19(8):e0308092. doi: 10.1371/journal.pone.0308092. eCollection 2024.
药物使用障碍与瑞典男性前列腺癌发病和死亡风险:一项全国性的流行病学研究。
Cancer Causes Control. 2022 Feb;33(2):213-222. doi: 10.1007/s10552-021-01513-2. Epub 2021 Nov 7.
4
Multiparametric MRI in the management of prostate cancer: an update-a narrative review.多参数磁共振成像在前列腺癌管理中的应用:最新进展——一篇叙述性综述
Gland Surg. 2020 Dec;9(6):2321-2330. doi: 10.21037/gs-20-561.
5
Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.抗高血压药物的使用与芬兰男性的前列腺癌特异性死亡率。
PLoS One. 2020 Jun 29;15(6):e0234269. doi: 10.1371/journal.pone.0234269. eCollection 2020.
6
What chance do we have to decrease prostate cancer overdiagnosis and overtreatment? A narrative review.我们有多大机会减少前列腺癌的过度诊断和过度治疗?一项叙述性综述。
Acta Biomed. 2019 Dec 23;90(4):423-426. doi: 10.23750/abm.v90i4.9070.
7
The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions.《世界癌症研究基金会/美国癌症研究所第三份关于饮食、营养、身体活动与癌症的专家报告:影响与未来方向》。
J Nutr. 2020 Apr 1;150(4):663-671. doi: 10.1093/jn/nxz268.
8
Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study.血清视黄醇与 ATBC 研究中总体和特定部位癌症风险的关系。
Am J Epidemiol. 2020 Jun 1;189(6):532-542. doi: 10.1093/aje/kwz226.
9
Epidemiology of Prostate Cancer.前列腺癌流行病学
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.
10
Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer.用于检测前列腺癌的前列腺磁共振成像(MRI),无论是否进行MRI靶向活检及系统活检。
Cochrane Database Syst Rev. 2019 Apr 25;4(4):CD012663. doi: 10.1002/14651858.CD012663.pub2.